Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Debt Ratio: 2010-2024

Historic Debt Ratio for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to 0.17.

  • China Pharma Holdings' Debt Ratio fell 32.50% to 0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.62, marking a year-over-year decrease of 15.79%. This contributed to the annual value of 0.17 for FY2024, which is 10.21% up from last year.
  • Per China Pharma Holdings' latest filing, its Debt Ratio stood at 0.17 for FY2024, which was up 10.21% from 0.15 recorded in FY2023.
  • In the past 5 years, China Pharma Holdings' Debt Ratio registered a high of 0.19 during FY2021, and its lowest value of 0.14 during FY2022.
  • Over the past 3 years, China Pharma Holdings' median Debt Ratio value was 0.15 (recorded in 2023), while the average stood at 0.15.
  • As far as peak fluctuations go, China Pharma Holdings' Debt Ratio soared by 37.16% in 2021, and later fell by 28.19% in 2022.
  • Yearly analysis of 5 years shows China Pharma Holdings' Debt Ratio stood at 0.14 in 2020, then skyrocketed by 37.16% to 0.19 in 2021, then fell by 28.19% to 0.14 in 2022, then climbed by 12.62% to 0.15 in 2023, then climbed by 10.21% to 0.17 in 2024.